SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-021023
Filing Date
2018-06-15
Accepted
2018-06-15 14:19:11
Documents
1
Period of Report
2018-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3336
  Complete submission text file 0001127602-18-021023.txt   4990
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Reporting) CIK: 0001627281 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38161 | Film No.: 18901856
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 600 COUNTY ROAD D WEST SUITE 8 NEW BRIGHTON MN 55112
Business Address 600 COUNTY ROAD D WEST SUITE 8 NEW BRIGHTON MN 55112 (651) 683-2807
Calyxt, Inc. (Issuer) CIK: 0001705843 (see all company filings)

IRS No.: 271967997 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2870 Agricultural Chemicals
Assistant Director 5